← The Wire
KNSANasdaq
Kiniksa Pharmaceuticals International, plc
Pharmaceutical Preparations · CIK 1730430
Developing and commercializing novel therapies for diseases with unmet need, focusing on cardiovascular indications
red 8-K · 90d
$3.99B
Market cap
$62.41
Last close
+5.4%
1D
+9.2%
5D
1.5M
Volume
Price · last 39 sessions+8.3%
May 4L $46.92 · H $62.41Jun 29
163
Total filings
May 29, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AApr 16, 2026DEF 14ADEF 14AApr 21, 2025DEF 14ADEF 14AApr 23, 2024DEF 14ADEF 14AApr 27, 2023DEF 14ADEF 14AApr 28, 2022DEF 14ADEF 14AApr 28, 2021DEF 14ADEF 14AApr 28, 2020DEF 14ADEF 14AApr 17, 2019
Insider Activity
In the 90 days to Mar 9, 2026: 4 sold $6.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 18,741 | $46.24 | $867K |
| Mar 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 17,981 | $45.58 | $820K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 22,223 | $44.88 | $997K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 12,063 | $44.20 | $533K |
| Mar 2, 2026 | Paolini John F.CHIEF MEDICAL OFFICER | Sell | 5,714 | $45.92 | $262K |
| Feb 12, 2026 | Quart Barry DDirector | Sell | 2,690 | $45.00 | $121K |
| Feb 10, 2026 | Quart Barry DDirector | Sell | 110 | $45.00 | $5K |
| Feb 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 9,114 | $42.85 | $391K |
| Feb 9, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 8,731 | $43.72 | $382K |
| Feb 4, 2026 | Quart Barry DDirector | Sell | 2,602 | $45.02 | $117K |
| Feb 3, 2026 | Quart Barry DDirector | Sell | 12,528 | $45.27 | $567K |
| Feb 2, 2026 | Quart Barry DDirector | Sell | 830 | $45.00 | $37K |
| Jan 8, 2026 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 12,000 | $41.89 | $503K |
| Dec 15, 2025 | Quart Barry DDirector | Sell | 20,129 | $41.51 | $836K |
| Dec 15, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 12,048 | $41.56 | $501K |
| Dec 8, 2025 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 42,841 | $41.49 | $1.8M |
| Nov 26, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 200 | $42.89 | $9K |
| Nov 17, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 11,825 | $41.30 | $488K |
| Nov 17, 2025 | Tessari EbenCHIEF OPERATING OFFICER | Sell | 645 | $40.08 | $26K |
| Nov 12, 2025 | Ragosa MarkCHIEF FINANCIAL OFFICER | Sell | 19,900 | $40.94 | $815K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance